The influence of comorbidities on the aging males’ symptoms scale in patients with erectile dysfunction

References

• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015;18:5–15
   PubMed Web of Science ®Google Scholar
• Martinez-Jabaloyas JM. Hipogonadism. Global epidemiology and transversal relationships. Arch Esp Urol 2013;66:632–8
   PubMed Web of Science ®Google Scholar
• Chantada AV, Vazquez-Martul PD, Portela PP, et al. Testosterone deficit syndrome in the old male. Arch Esp Urol 2013;66:684–8
   PubMed Web of Science ®Google Scholar
• Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clin Proc 2016;91:881–96
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59
   PubMed Web of Science ®Google Scholar
• Langham S, Maggi M, Schulman C, et al. Health-related quality of life instruments in studies of adult men with testosterone deficiency syndrome: a critical assessment. J Sex Med 2008;5:2842–52
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, O'Donnell AB, et al. A population-level decline in serum testosterone levels in American men. J Clin Endrocrinol Metab 2007;92:196–202
   PubMed Web of Science ®Google Scholar
• Valero RJ, Marquez LJ, Campos HP, et al. Current recommendations about the diagnosis and treatment of testosterone deficit syndrome: clinical guidelines. Arch Esp Urol 2013;66:737–44
   PubMed Web of Science ®Google Scholar
• Heinemann LA. Aging Males' Symptoms scale: a standardized instrument for the practice. J Endocrinol Invest 2005;28:34–8
   PubMedGoogle Scholar
• Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endrocrinol Metab 2004;89:5920–6
   PubMed Web of Science ®Google Scholar
• Lee DM, O'Neill TW, Pye SR, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009;32:11–24
   PubMedGoogle Scholar
• Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30:10–22
   PubMed Web of Science ®Google Scholar
• Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009;30:23–32
   PubMedGoogle Scholar
• Pitteloud N, Hardin M, Dwyer AA, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005;90:2636–41
   PubMed Web of Science ®Google Scholar
• Martinez-Jabaloyas JM, DE-SDT study group. Testosterone deficiency in patients with erectile dysfunction: when should a higher cardiovascular risk be considered? J Sex Med 2014;11:2083–91
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335–43
   PubMed Web of Science ®Google Scholar
• Zarotsky V, Huang MY, Carman W, et al. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology 2014;2:819–34
   PubMed Web of Science ®Google Scholar
• Garcia-Cruz E, Leibar-Tamayo A, Romero-Otero J, et al. Marked testosterone deficiency-related symptoms may be associated to higher metabolic risk in men with low testosterone levels. J Sex Med 2014;11:2292–301
   PubMed Web of Science ®Google Scholar
• Delhez M, Hansenne M, Legros JJ. Testosterone and depression in men aged over 50 years. Andropause and psychopathology: minimal systemic work-up. Ann Endocrinol 2003;64:162–9
   PubMed Web of Science ®Google Scholar
• Emmelot-Vonk MH, Verhaar HJ, Nakhai-Pour HR, et al. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) 2011;74:488–94
   PubMed Web of Science ®Google Scholar
• Chueh KS, Huang SP, Lee YC, et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl 2012;33:817–23
   PubMedGoogle Scholar
• Tang WH, Zhuang XJ, Shu RM, et al. The prevalence of erectile dysfunction among subjects with late-onset hypogonadism: a population-based study in China. Int J Clin Exp Med 2015;8:13901–10
   PubMed Web of Science ®Google Scholar
• Bhattacharya RK, Bhattacharya SB. Late-onset hypogonadism and testosterone replacement in older men. Clin Geriatr Med 2015;31:631–44
   PubMed Web of Science ®Google Scholar
• Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metab Clin Exp 2000;49:1239–42
   PubMed Web of Science ®Google Scholar
• Gladh YM, Rahgozar M, Hammar ML, et al. Prevalence of symptoms possibly related to PADAM, in a Swedish population aged 55, 65 and 75 years. Maturitas 2005;50:161–6
   PubMed Web of Science ®Google Scholar
• Martinez-Jabaloyas JM, Queipo-Zaragoza A, Rodriguez-Navarro R, et al. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age. Eur Urol 2007;52:1760–7
   PubMed Web of Science ®Google Scholar
• Moore C, Huebler D, Zimmermann T, et al. The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004;46:80–7
   PubMed Web of Science ®Google Scholar
• Daig I, Heinemann LA, Kim S, et al. The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes 2003;1:77
   PubMedGoogle Scholar
• Legros JJ, Meuleman EJ, Elbers JM, et al. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Eur J Endocrinol 2009;160:821–31
   PubMed Web of Science ®Google Scholar
• Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes 2003;1:15
   PubMedGoogle Scholar